# Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock

> **NCT01046669** · NA · COMPLETED · sponsor: **Spectral Diagnostics (US) Inc.** · enrollment: 450 (actual)

## Conditions studied

- Septic Shock
- Endotoxemia

## Interventions

- **DEVICE:** TORAYMYXIN PMX-20R (PMX cartridge)
- **OTHER:** Standard medical care for septic shock

## Key facts

- **NCT ID:** NCT01046669
- **Lead sponsor:** Spectral Diagnostics (US) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2016-07
- **Final completion:** 2017-06
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046669, "Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01046669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*